Results suggested that extremely high EGFR expression could be associated with better RFS in all breast cancer subtypes except Luminal A although this did not reach statistical significance.
← all excerpts
A Five-Biomarker IHC-Based Signature Predicting Outcome in Breast Cancer Patients Following Adjuvant Anthracycline-Based Chemotherapy.
1
—
—